Abiopharma

🔍 Richie Laurel (Director)

Company: Synchrony Financial (SYF)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Acquired 138 shares of Dividend Equivalent Unit at $80.75 per share (Direct)
  Date: 2026-08-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 51,824.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2

Footnotes:

• F1: Represents dividend equivalent units accrued on August 17, 2026 as dividends that were paid on the common shares underlying restricted stock units and deferred stock units previously granted to the Reporting Person under the Company's Long-Term Incentive Plans and Non-Employee Director Deferred Compensation Plan. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.
• F2: Balance adjusted to account for rounding of fractional shares over time.